LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 73 filers reported holding LEGEND BIOTECH CORP in Q1 2021. The put-call ratio across all filers is 3.21 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $26,139,000 | -27.9% | 475,263 | -52.4% | 10.25% | -22.8% |
| Q1 2022 | $36,257,000 | +38.8% | 997,714 | +78.0% | 13.28% | -26.8% |
| Q4 2021 | $26,125,000 | -8.5% | 560,506 | -0.8% | 18.14% | -27.5% |
| Q3 2021 | $28,557,000 | +32.2% | 564,806 | +7.4% | 25.01% | +120.2% |
| Q2 2021 | $21,595,000 | +99.5% | 526,072 | +41.0% | 11.36% | +33.2% |
| Q1 2021 | $10,824,000 | +42.9% | 372,989 | +38.6% | 8.53% | +52.8% |
| Q4 2020 | $7,577,000 | – | 269,072 | – | 5.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 814,586 | $56,230,872 | 17.46% |
| Paradigm Biocapital Advisors LP | 1,805,717 | $124,648,645 | 9.63% |
| HHLR ADVISORS, LTD. | 6,436,533 | $444,313,873 | 9.46% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,123,692 | $77,568,459 | 9.09% |
| RA Capital Management | 6,264,707 | $432,452,724 | 8.16% |
| Tri Locum Partners LP | 116,768 | $8,060,495 | 3.00% |
| Nicholas Investment Partners, LP | 593,167 | $40,946,318 | 2.80% |
| E Fund Management (Hong Kong) Co., Ltd. | 51,679 | $3,567 | 2.66% |
| Avidity Partners Management LP | 798,900 | $55,148,067 | 1.93% |
| Boxer Capital, LLC | 600,000 | $41,418 | 1.92% |